Cargando…
Assessment of quality benchmarks in adenoma detection in Mexico
Background and study aims Several Latin American countries, including Mexico, have reported an increase in colorectal cancer (CRC) mortality. The effectiveness of a colonoscopy in preventing CRC depends on the quality of the procedure, for which the adenoma detection rate (ADR) is one of the most t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159590/ https://www.ncbi.nlm.nih.gov/pubmed/34079860 http://dx.doi.org/10.1055/a-1396-3718 |
_version_ | 1783700122666795008 |
---|---|
author | Aguilar-Olivos, Nancy E. Balanzá, Ricardo Rojas-Mendoza, Fernando Soto-Solis, Rodrigo Ballesteros-Amozurrutia, Mario A. González-Uribe, Norma Fernández-Rivero, Justo A. |
author_facet | Aguilar-Olivos, Nancy E. Balanzá, Ricardo Rojas-Mendoza, Fernando Soto-Solis, Rodrigo Ballesteros-Amozurrutia, Mario A. González-Uribe, Norma Fernández-Rivero, Justo A. |
author_sort | Aguilar-Olivos, Nancy E. |
collection | PubMed |
description | Background and study aims Several Latin American countries, including Mexico, have reported an increase in colorectal cancer (CRC) mortality. The effectiveness of a colonoscopy in preventing CRC depends on the quality of the procedure, for which the adenoma detection rate (ADR) is one of the most trusted indicators. Awareness of ADR can improve the quality of colonoscopies through proper feedback and training of the specialists. The goal of this study was to estimate the ADR among Mexican endoscopists with experience in CRC screening and to compare it with previously reported data from this country. Methods We carried out a retrospective study to analyze ADR data in Mexico. The information was obtained from a group of certified endoscopists and compared with the former published data from Mexico. Results We found a current ADR of 24.6 % (95 %CI, 22.4 %–26.8 %) from 1,478 colonoscopies performed by eight endoscopists in two third-level private hospitals. The average ADR reported in previous publications was 15.2 % (95 %CI, 13.3 %–17.1 %). Statistical analysis showed differences between our results and those from previous studies (24.6 % vs. 15.2 %, P < 0.001). Conclusions The actual ADR in Mexico is higher than previously reported. Previous low ADR values could be explained by poorly performed colonoscopies rather than by low adenoma and CRC incidence in our country. |
format | Online Article Text |
id | pubmed-8159590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-81595902021-06-01 Assessment of quality benchmarks in adenoma detection in Mexico Aguilar-Olivos, Nancy E. Balanzá, Ricardo Rojas-Mendoza, Fernando Soto-Solis, Rodrigo Ballesteros-Amozurrutia, Mario A. González-Uribe, Norma Fernández-Rivero, Justo A. Endosc Int Open Background and study aims Several Latin American countries, including Mexico, have reported an increase in colorectal cancer (CRC) mortality. The effectiveness of a colonoscopy in preventing CRC depends on the quality of the procedure, for which the adenoma detection rate (ADR) is one of the most trusted indicators. Awareness of ADR can improve the quality of colonoscopies through proper feedback and training of the specialists. The goal of this study was to estimate the ADR among Mexican endoscopists with experience in CRC screening and to compare it with previously reported data from this country. Methods We carried out a retrospective study to analyze ADR data in Mexico. The information was obtained from a group of certified endoscopists and compared with the former published data from Mexico. Results We found a current ADR of 24.6 % (95 %CI, 22.4 %–26.8 %) from 1,478 colonoscopies performed by eight endoscopists in two third-level private hospitals. The average ADR reported in previous publications was 15.2 % (95 %CI, 13.3 %–17.1 %). Statistical analysis showed differences between our results and those from previous studies (24.6 % vs. 15.2 %, P < 0.001). Conclusions The actual ADR in Mexico is higher than previously reported. Previous low ADR values could be explained by poorly performed colonoscopies rather than by low adenoma and CRC incidence in our country. Georg Thieme Verlag KG 2021-06 2021-05-27 /pmc/articles/PMC8159590/ /pubmed/34079860 http://dx.doi.org/10.1055/a-1396-3718 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Aguilar-Olivos, Nancy E. Balanzá, Ricardo Rojas-Mendoza, Fernando Soto-Solis, Rodrigo Ballesteros-Amozurrutia, Mario A. González-Uribe, Norma Fernández-Rivero, Justo A. Assessment of quality benchmarks in adenoma detection in Mexico |
title | Assessment of quality benchmarks in adenoma detection in Mexico |
title_full | Assessment of quality benchmarks in adenoma detection in Mexico |
title_fullStr | Assessment of quality benchmarks in adenoma detection in Mexico |
title_full_unstemmed | Assessment of quality benchmarks in adenoma detection in Mexico |
title_short | Assessment of quality benchmarks in adenoma detection in Mexico |
title_sort | assessment of quality benchmarks in adenoma detection in mexico |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159590/ https://www.ncbi.nlm.nih.gov/pubmed/34079860 http://dx.doi.org/10.1055/a-1396-3718 |
work_keys_str_mv | AT aguilarolivosnancye assessmentofqualitybenchmarksinadenomadetectioninmexico AT balanzaricardo assessmentofqualitybenchmarksinadenomadetectioninmexico AT rojasmendozafernando assessmentofqualitybenchmarksinadenomadetectioninmexico AT sotosolisrodrigo assessmentofqualitybenchmarksinadenomadetectioninmexico AT ballesterosamozurrutiamarioa assessmentofqualitybenchmarksinadenomadetectioninmexico AT gonzalezuribenorma assessmentofqualitybenchmarksinadenomadetectioninmexico AT fernandezriverojustoa assessmentofqualitybenchmarksinadenomadetectioninmexico |